First-in-Man Safety, Tolerability, and Pharmacokinetics of a Novel and Highly Selective Inhibitor of Matrix Metalloproteinase-12, FP-025: Results from Two Randomized Studies in Healthy Subjects
暂无分享,去创建一个
Z. Diamant | C. Voors‐Pette | Kang-Ling Wang | Khalid Abd-Elaziz | David Lau | J. Mao | Yisheng Lee | Sandy Pan | Yuhua Li | Benjamin Chien